Nobel Prize awards 12 million kronor shared among optogenetics pioneers
Three optogenetics scientists share 12 million Swedish kronor Nobel Prize award.
Event / Science
Nobel Prize Physiology Medicine 2026
The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for discoveries of light-gated ion channels and development of optogenetics, enabling control of nerve cells with light for brain mapping and neurological treatment applications.
5 reported locations
Daily activity
6 articles0 articles
2026-10-05 to 2026-10-30 · UTC publication dates
Coverage begins 5 Oct, 14:48 UTC
Follow the documented timeline or explore the related reporting.
What happened
Karl Deisseroth demonstrated optogenetics in mammalian nerve cells
Karl Deisseroth at Stanford University demonstrated the optogenetics technique in rat nerve cells in 2005, showing that introducing channelrhodopsin genes could trigger nerve signals using blue light. By 2007, he successfully applied the light-controlled switch for nerve cells in the brains of living mice. The method was formally named optogenetics in 2006.
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discoveries
The Nobel Assembly at Karolinska Institutet awarded the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth (USA), Peter Hegemann (Germany), and Georg Nagel (Germany) for their discoveries concerning light-gated ion channels and optogenetics. The prize recognizes their work developing a method that uses light to control individual nerve cells in the brain.
Optogenetics enables light-based control of nerve cells for brain research
Optogenetics is a technique that uses light-sensing proteins called rhodopsins to control individual cells, particularly brain cells. The method allows scientists to switch nerve cells on or off using light, enabling precise understanding of how specific neurons and neural pathways govern behavior including eating, sociability, and aggression. This has revolutionized neuroscience by providing direct insight into brain activity and function.
Peter Hegemann and Georg Nagel discovered channelrhodopsin protein in algae
In the early 1990s and 2000s, Peter Hegemann and Georg Nagel discovered channelrhodopsin-2, a light-sensitive ion channel protein found in the single-celled alga Chlamydomonas. Hegemann began investigating how the alga responds to light, and Nagel tested the hypothesis by injecting Chlamydomonas genes into frog eggs, discovering the remarkable protein. In 2003, they published findings showing the protein could be introduced into human cells to generate electrical impulses using light.
Optogenetics reveals brain circuits linked to neurological and psychiatric disorders
Using optogenetics, researchers have identified neural circuits governing specific memories, feelings, and behaviors relevant to neurological and psychiatric disorders. Animal models are being used to understand schizophrenia, Alzheimer's disease, Parkinson's disease, epilepsy, and addiction—conditions affecting millions worldwide with limited treatment options. The technique has illuminated how specific brain circuits are disrupted in these diseases.
Nobel Prize carries 12 million Swedish kronor award shared equally among laureates
The 2026 Nobel Prize in Physiology or Medicine carries a monetary award of 12 million Swedish kronor (approximately $1.2 million USD) to be shared equally among the three laureates: Karl Deisseroth, Peter Hegemann, and Georg Nagel.
Optogenetics enables precise control of individual mouse motor and behavioral functions
Karl Deisseroth used optogenetics to control the movements of mouse whiskers by activating specific nerve cells in the motor cortex. He also used light to wake sleeping mice, confirming that specific nerve cells control wakefulness. These experiments demonstrated the precision and specificity of optogenetic control over neural circuits governing distinct behaviors.
Optogenetics being tested to restore vision in retinitis pigmentosa patients
Researchers are applying optogenetics in clinical trials to restore sight in people blinded by retinitis pigmentosa, a progressive eye disease causing light-sensing cells in the eye to die. The treatment involves injecting DNA encoding for a light-sensing protein into retinal neurons, enabling them to activate and send electrical signals to the brain when exposed to light, bypassing dead and damaged cells. Nanoscope, a US biotechnology company, is developing an advanced treatment for this condition.
Optogenetics research reveals brain circuits underlying behavior and disease
Optogenetics research has identified specific brain circuits and neural pathways responsible for behavior and various diseases. Using the technique, scientists have mapped how specific neurons control functions such as wakefulness and whisker movement in mice. The research has provided insights into conditions including schizophrenia, Alzheimer's disease, Parkinson's disease, epilepsy, addiction, depression, and dementia, transforming neuroscience from fixed brain activity maps to functional wiring diagrams.
2026 Nobel Prize in Physiology or Medicine awarded to three neuroscience researchers
The Nobel Assembly at Karolinska Institutet awarded the 2026 Nobel Prize in Physiology or Medicine to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their discoveries concerning light-gated ion channels and optogenetics. The prize was announced on October 5, 2026, and carries a monetary award of 12 million Swedish kronor (approximately $1.2 million) to be shared equally among the three laureates.
2026 Nobel Prize announcements follow medicine award with physics, chemistry, and literature prizes
The 2026 Nobel Prize week began with the medicine prize announcement on Monday, October 5. The physics prize was scheduled to be announced on Tuesday, chemistry on Wednesday, and literature on Thursday. The peace prize would be awarded on Friday, followed by the Nobel Memorial Prize in Economic Sciences on October 12.
Karl Deisseroth develops optogenetics technique to control brain neurons with light
Karl Deisseroth, a 54-year-old Stanford University professor and Howard Hughes Medical Institute investigator, developed the optogenetics technique by introducing channelrhodopsin genes into nerve cells in living mouse brains. This allowed precise control of neurons using light delivered through tiny fibers and later through noninvasive methods. The technique enables scientists to turn specific neurons on or off while observing animal behavior, providing unprecedented temporal precision in neural control at the millisecond scale.
Deisseroth receives Nobel Prize notification while working late at home
Karl Deisseroth was working late in his Northern California home when he received the Nobel Assembly's call informing him of his prize. The self-described night owl was working on papers and emailing students when he had just gone to bed. He stated that he was so surprised that he 'almost couldn't speak for a little bit.' After receiving the call, his immediate priority was to pack school lunches for his children.
Hegemann and Nagel discover light-sensitive proteins in algae
Peter Hegemann of Humboldt University in Berlin and Georg Nagel discovered channelrhodopsin, light-sensitive proteins in single-celled green algae. Hegemann initially explored how the algae swim toward light, leading to the discovery that the protein responds to blue light by opening an ion channel to create electrical impulses. In 2003, Hegemann and Nagel published findings demonstrating that this protein could be introduced into human cells to generate electrical impulses using light.
Clinical applications of optogenetics emerge for vision restoration and neurological disorders
Multiple biotechnology companies are developing clinical treatments based on optogenetics research. Ray Therapeutics is advancing a therapy for retinitis pigmentosa, a genetic form of blindness, by inserting light-activated proteins into the retina paired with special light-emitting glasses. MapLight, co-founded by Deisseroth, is developing a therapy for autism spectrum disorder. Nanoscope is developing a vision restoration treatment for retinitis pigmentosa. Researchers are also exploring applications to improve cochlear implants for hearing restoration.
Optogenetics enables mapping of brain circuits controlling memories, emotions, and behaviors
Optogenetics, the technique developed through the work of the Nobel laureates, provides unprecedented capabilities for brain mapping and understanding neural circuits. The method allows researchers to reveal how specific types of cells contribute to behaviors including learning, fear, addiction, and movement. The technique has fundamentally altered understanding of the brain and provides research foundations for potential treatments of neurological and psychiatric disorders such as Parkinson's disease and epilepsy.
Peter Hegemann and Georg Nagel discover channelrhodopsin protein in unicellular algae
German researchers Peter Hegemann and Georg Nagel discovered a protein called channelrhodopsin in a unicellular algae (Chlamydomonas). Hegemann initially investigated how the algae could swim toward light sources. Nagel, in the early 2000s, identified the channelrhodopsin protein, which under blue light opens a channel allowing ions to enter and generate electrical impulses. The researchers demonstrated that any cell into which this protein is introduced becomes light-sensitive.
2026 Nobel Prize season opens with medicine award, continues through October 12
The 2026 Nobel Prize season opened with the announcement of the Physiology or Medicine award on October 5 and will continue through October 12 with announcements of laureates in physics, chemistry, literature, peace, and economics.
2026 Nobel Prize in Physiology or Medicine awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel
The Nobel Prize in Physiology or Medicine for 2026 was awarded to American Karl Deisseroth and Germans Peter Hegemann and Georg Nagel. The prize was announced on Monday, October 5, 2026, by the Nobel Committee at the Karolinska Institute in Stockholm. The trio was recognized for their discoveries concerning light-gated ion channels and optogenetics, a method that enables researchers to demonstrate how nerve cells shape memories, emotions, and behaviors in the brain.
Karl Deisseroth develops optogenetics technique using light-activated ion channels
American psychiatrist and neurologist Karl Deisseroth introduced the channelrhodopsin gene into nerve cells of rats and successfully triggered nerve signals by illuminating the cells with blue light. This major discovery was published in 2005. Two years later, Deisseroth successfully demonstrated the light-controlled nerve cell activation in the brains of living mice, transforming the channelrhodopsin protein into a light-controlled switch for nerve cells.
Read the coverage
2 alternative perspectives
Light-based optogenetics opens new pathways for treating brain disorders
Optogenetics moves toward clinical practice with trials treating vision disorders through light-controlled brain cells.
How foundational algae discovery became breakthrough brain control technique
Algae protein discovery evolved into brain control technology through sequential scientific contributions across institutions and decades.
Optogenetics moves from lab discovery toward treating human neurological disease
Optogenetics moves toward clinical applications for vision restoration and neurological disorder treatment.
Meet the three neuroscientists behind optogenetics' Nobel win
Three neuroscientists won the 2026 Nobel for optogenetics discoveries spanning algal proteins to neural control techniques.
Light-activated proteins earn Nobel Prize for brain mapping breakthrough
Nobel Prize honors optogenetics discovery, enabling precise light-based control of brain activity for research and medical applications.